2025 House Resolution 119

A resolution to declare June 3, 2025, as Brain Cancer Awareness Day in the state of Michigan.

Whereas, Brain tumors, particularly glioblastoma, are recognized as among the deadliest forms of cancer, with a five-year relative survival rate of only 6.9 percent; and

Whereas, In 2025, it is estimated that approximately 780 Michigan residents will be diagnosed with a brain tumor and an estimated 610 residents will succumb to this disease; and

Whereas, Brain cancer remains the leading cause of cancer-related deaths among children ages 0-14 and young adults ages 15-39; and

Whereas, Brain tumors impose the highest per-patient initial cost of care among all cancers, with an annualized mean net cost approaching $162,550 in 2019 U.S. dollars; and

Whereas, More than any other cancer, brain tumors can cause profound and lasting physical, cognitive, and psychological impacts that affect the quality of life of patients and survivors; and

Whereas, Michigan has gained national recognition as a center of excellence in brain tumor treatment and research, with institutions such as the Hermelin Brain Tumor Center at Henry Ford Health and the Children’s Hospital of Michigan leading clinical trials, attracting grant funding, and drawing patients from across the country; and

Whereas, Despite the significant number of diagnoses and the often-devastating prognosis, only five drugs and one medical device have been approved by the U.S. Food and Drug Administration for brain tumor treatment over the past 30 years, with none proven curative and only modest extensions in survival; and

Whereas, Mortality rates for brain tumors, including glioblastoma, have remained largely unchanged over the past three decades, underscoring the urgent need for greater public awareness, research, and treatment innovation; now, therefore, be it

Resolved by the House of Representatives, That the members of this legislative body declare June 3, 2025, as Brain Cancer Awareness Day in the state of Michigan. We honor patients and families affected by this disease, recognize Michigan’s leadership in brain tumor research and treatment, and encourage continued advocacy and vigilance in healthcare.